Daniel Malone, RPh, PhD
Daniel C. Malone, RPh, PhD, is a professor at the College of Pharmacy and associate professor in Mel and Enid Zuckerman College of Public Health at the University of Arizona. He received a bachelor of science degree in pharmacy from the University of Colorado (magna cum laude) in 1987. Dr. Malone received a MS degree in 1990 and PhD degree in 1993 from The University of Texas. He completed an Agency for Healthcare Research and Quality (AHRQ) postdoctoral fellowship at the Departments of Public Health and Community Medicine and Pharmacy at the University of Washington. Prior to joining the University of Arizona he was an assistant professor at the University of Colorado.
Dr. Malone is currently the principal investigator on an AHRQ-funded dissemination grant to pharmacy and therapeutic committees on comparative effectiveness research. His current research interests include: developing strategies to prevent drug-drug interactions; improving health care professionals' knowledge of statistical and research methods; and evaluating the economic value of medical technologies. Dr. Malone has over 100 peer-review research publications and has been successful in obtaining over $15 million in extramural support for his research endeavors.
Dr. Malone has conducted numerous research projects and economic studies of pharmaceuticals and healthcare technologies and policy issues associated with the use of pharmaceuticals. Dr. Malone’s research projects have involved a number of organizations, including the Department of Veterans, Kaiser Permanente, the state of Arizona’s Medicaid program, various managed care organizations and affiliated providers, and hospital systems.
BS, University of Colorado, 1987
MS, University of Texas, 1990
PhD, University of Texas, 1993
Postdoctoral Fellow, University of Washington, 1993-94
Hines LE, Malone DC, Murphy JE. Recommendations for generating, evaluating, and implementing drug-drug interaction evidence. Pharmacotherapy 2012;32:304-13
Brown MR, Leib ML, Brown SR, Warholak T, Malone DC. The appropriateness of use of 3 classes of psychotropic medications in children and adolescents. American Journal of Pharmacy Benefits 2012;4(2):49-56.
Tang DH, Malone DC. A network meta-analysis of efficacy of serotonin type 3 receptor antagnoists used in adults during first 24 hours for postoperative nausea and vomiting prophylaxis. Clinical Therapeutics 2012; 34:282-294.
Dworkin RH, Panarities CJ, Armstrong EP, Malone DC, Pham SV. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? Pain 2012; 153:869-875.
Hincapie AL, Warholak TL, Hines LE, Taylor AM, Malone DC. Impact of a drug-drug interaction intervention on pharmacy and medical students’ knowledge and attitudes: a 1-year follow-up. Research in Social and Administrative Pharmacy 2012; doi:10.1016/j.sapharm.2011.11.003.
Malone DC, Saverno KR. Evaluation of wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population. Journal of Managed Care Pharmacy 2012; 18:33-45.
Hines LE, Boesen MD, Warholak TL, Saverno KR, Boesen MD, Sisk MA, Malone DC. Drug-Drug Interaction Software Quality Assurance: Lessons Learned. Journal of the American Pharmacists Association 2011:51:570-572.
Gilligan AM, Warholak TL, Murphy JE, Hines LE, Malone DC. Pharmacy students’ retention of knowledge of drug-drug interactions. American Journal of Pharmaceutical Education 2011; 75 (6): Article 110.
Warholak TL, Holdford DA, West D, DeBake DL, Bentely JP, Malone DC, Murphy JE. American Journal of Pharmaceutical Education 2011; 75(7):Article 142.
Holford DA, Warholak TL, Strum-West D, Bentley JP, Malone DC, Murphy JE, Marchand H. Teaching the Science of Safety in U.S. Schools of Pharmacy. American Journal of Pharmaceutical Education 2011; 75(4):Article 77.
Hines LE, Murphy JE, Grizzle AJ, Malone DC. Critical issues associated with drug-drug interactions: highlights from a multistakeholder conference. American Journal of Health-System Pharmacy 2011 68:941-946.
Warholak TL, Hines LE, Saverno KR, Grizzle AJ, Malone DC. An assessment tool for pharmacy drug-drug interaction software. Journal of the American Pharmacists Association 2011; 51: 418-424.
Hines LE, Saverno TL, Warholak TL, Taylor A, Grizzle AJ, Murphy JE. Malone DC. Pharamcists’ awareness of clinical decision support in pharmacy information systems: an exploratory evaluation. Research in Social and Administrative Pharmacy (in press).
Armstrong EP, Malone DC, McCarberg B, Panarites CJ, Pham SV. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for Postherpetic neuralgia. Current Medical Research & Opinion 2011; 27:939-50.
Warholak TL, Hines LE, Song MC, Gessay A, Menke JM, Sherrill D, Reel S, Murphy JE, Malone DC. Medical, nursing, and pharmacy students’ ability to recognize potential drug-drug interactions: a comparison of healthcare professional students. Journal of the American Academy of Nurse Practitioners 2011; 23: 216-221.
Warholak TL, Menke M, Hines LE, Reel S, Murphy J, Sherril D, Malone DC. A drug-drug knowledge assessment instrument for health professional students: A Rasch analysis of validity evidence. Research in Social and Administrative Pharmacy 2011; 7:16-26
Dworkin RH, Panarites CJ, Armstrong EP, Malone DC, Pham SV. Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathy. Journal of the American Geriatrics Association 2011; 59:827-36.
Hines LE, Ceron-Cabrera D, Armstrong EP, Anthony M, Romero K, Woosley RL, Malone DC. Evaluation of warfarin interactions listed in FDA-approved prescribing information for warfarin and drugs known to interact with warfarin. Clinical Therapeutics 2011; 33:36-45.
Saverno KR, Hines LE, Warholak TL, Grizzle AJ, Babits L, Clark C, Taylor AM, Malone DC. Ability of pharmacy clinical decision support software to alert users about clinically important drug-drug interactions. Journal of the American Medical Informatics Association 2011: 18:32-37.
Hincapie AL, Warholak TL, Murcko A, Slack M, Malone DC. Physicians’ opinions of a health information exchange. Journal of the American Medical Informatics Association 2011; 18:60-65.
Hess LM, Malone DC, Skrepnek GH, Reed PG, Armstrong EP, Weihs K. Preferences of patients and oncologists for advanced ovarian cancer treatment-related health states. Health Outcomes and Research in Medicine 2010; 1(e51-e59).
Higgins L, Brown M, Murphy JE, Malone DC, Armstrong EP, Woosley RL. Community pharmacy and pharmacist-staff call center assessment of medication safety and effectiveness: a feasibility study. Journal of the American Pharmacists Association 2011; 51:82-89
Malone DC, Waters HC, Van Den Bos J, Popp J, Draahtel K, Rahman MI. A claims-based Markov model for Crohn’s disease. Alimentary Pharmacology and Therapeutics 2010; 32:448-458.
Daniel GW, Ewen E, Willey VJ, Reese C, Shirazi F. Malone DC. Efficiency and economic benefits of a payer-based electronic health record in an emergency department. Academic Emergency Medicine 2010; 17:824-833.
Charland SL, Malone DC. Prediction of cardiovascular event reduction from lipid changes associated with high potency dyslipidemia therapy. Current Medical Research & Opinion 2010; 26(2):365-375.
Olvey EL, Clauschee S, Malone DC. Comparison of critical drug-drug interactions from the Department of Veteran’s Affairs medical system to standard reference compendia. Clinical Pharmacology and Therapeutics 2010; 87:48-51.
Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV. Impact of postherpectic neuralgia and painful diabetic peripheral neuropathy on health care costs. Journal of Pain 2009; eprint ahead of pub)
Malone DC, Boudreau DM, Nichols GA, Raebel MA, Fishman PA, Feldstein AC, Ben-Joseph RH, Okamoto LJ, Boscoe A, Magid DJ. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metabolic Syndrome and Related Disorders 2009; 7:585-594.
Hess LM, Malone DC, Skrepnek GH, Reed PG, Armstrong EP, Coons SJ. Oncologist preferences for health states associated with the treatment of advanced ovarian cancer. Applied Health Economics and Health Policy 2010;8:217-223.
Anthony M, Romero K, Malone DC, Hines L, Higgins L, Woosley, RL. Warfarin interactions listed in drug information compendia and the FDA approved label for warfarin sodium (Coumadin®). Clinical Pharmacology and Therapeutics 2009; 86:425-9.
Malone DC, McLaughlin TP, Wahl P, Leibman C, Arrighi HM, Cziraky MJ, Mucha LM. Burden of Alzheimer’s disease and associated negative health outcomes. American Journal of Managed Care 2009; 15;481-488.
Boudreau DM, Malone DC, Raebel MR, Fishman PA, Nichols GA, Feldstein AC, Hill A, Boscoe AN, Ben-Joseph R, Magid DJ, Okamoto LJ. Health care utilization and costs by metabolic syndrome risk factors. Metabolic Syndrome and Related Disorders 2009;7(4):305-314.
Saverno KR, Malone DC, Kurowsky J. Pharmacy students’ ability to identify potential drug-drug interactions. American Journal of Pharmaceutical Education 2009; 73(2):Article 27.
Brixner DI, Holtorf AP, Neumann PJ, Malone DC, Watkins JB. Standardizing quality assessment of observational studies for decision making in health care. Journal of Managed Care Pharmacy 2009; 15:275-283.
Smith K, Warholak T, Armstrong EP, Leib M, Rehfield R, Malone DC. Evaluation of risk factors and health outcomes among persons with asthma. Journal of Asthma 2009; 46:234-237.
Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH. Development of computerized alert with management strategy for 25 serious drug-drug interactions. American Journal of Health-Systems Pharmacy 2009; 66:38-44.
Ko Y, Malone DC, D’Agostino JV, Skrepnek GH, Armstrong EP, Brown M, Woosley RL. Potential determinants of prescribers’ drug-drug interaction knowledge. Research in Social and Administrative Pharmacy 2008; 4:355-366.
Mahmood MH. Armstrong EP. Malone DC. Skrepnek GH. Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers. American Journal of Health-System Pharmacy 2008; 65(18):1744-9.
Anthony M, Lee KY, Bertram CT, Abarca J, Rehfeld RA, Malone DC, Freeman M, Woosley RL. Gender and age differences in medications dispensed from a national chain drug store. Journals of Women’s Health 2008; 17:735-743.
Ko Y, Malone DC, Skrepnek GH, Armstrong EP, Murphy JE, Abarca J, Rehfeld RA, Reel SJ, Woosley RL. Prescribers knowledge of and source for drug-drug interaction information. Drug Safety 2008; 31:525-536.
Armstrong EP. Malone DC. Erder MH. A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder. Current Medical Research & Opinion 2008; 24(4):1115-21.
Wang MT, Skrepnek GH, Armstorng EP, Sherrill DL, Harris RB. Tsai CL, Malone DC. Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma. Current Medical Opinion and Research 2008; 24:859-867.
Grizzle AJ, Murphy JE, Mahmood M, Armstrong EP, Skrepnek GH, Woosley RL, Jones WN, Schepers GP, Nichol P, Houranieh A, Dare DC, Hoey CT, Malone DC. Reasons provided by prescribers when overriding drug-drug interaction alerts. American Journal of Managed Care 2007;13:573-580.
Mahmood M, Malone DC, Skrepnek GH, Abarca J, Armstrong EP, Murphy JE, Grizzle AJ, Ko Y, Woosley RL. Assessment of potential drug-drug interactions within the Veterans Affairs medical centers. American Journal of Health-Systems Pharmacy 2007;64:1500-1505.
Yeh WS, Armstrong EP, Skrepnek GH, Malone DC. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy 2007; 27:813-24.
Malone DC, Abarca J, Skrepnek GH, Murphy JE, Grizzle AJ, Rehfeld RA, Woosley RL. Pharmacist workload and pharmacy characteristics associated with dispensing of potentially clinically important drug-drug interactions. Medical Care 2007; 45:456-462.
Hess LM, Benham-Hutchins M, Herzog TJ, Hsu CH, Malone DC, Skrepnek GH, Slack MK, Alberts DS. A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. International Journal of Gynecological Cancer2007; 17:561-570.
Daniel GW. Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs. Journal of Managed Care Pharmacy 2007; 13:142-154.
Ko Y, Abarca J, Malone DC, Dare DC, Geraets D, Houranieh A, Jones WN, Nichol WP, Schepers GP, Wilhardt M. Practitioners’ views on computerized drug-drug interaction alerts in the VA system. Journal of the American Medical Informatics Association 2007; 14:56-64.
Ko Y, Malone DC, Armstrong EP. A pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder. Pharmacotherapy 2006; 26:1694-1702.
Hess LM, Raebel MR, Conner DA, Malone DC. The measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Annals of Pharmacotherapy 2006; 40:1280-1288.
Murphy JE, Malone DC, Skrepnek GH, Armstrong EP, Abarca J, Grizzle AJ, Rehfeld R, Woosley RL. The role of technicians in the management of computerized drug-drug interaction alerts in community pharmacies. Journal of Pharmacy Technology 2006; 22:155-160.
Abarca J, Colon LR, Wang VS, Malone DC, Murphy JE, Armstrong EP. Evaluation of drug-drug interaction screening software in community and hospital pharmacies. Journal of Managed Care Pharmacy 2006; 12:383-389.
Perkins NA, Murphy JE, Armstrong EP, Malone DC. Performance of drug-drug interaction software for personal digital assistants. Pharmacotherapy 2006; 40:850-855.
Johnson L, Strich H, Taylor A, Timmerman B, Malone D, Teufel-Shone N, Drummond R, Woosley R, Pereira E, Martinez A. Use of herbal remedies by diabetic Hispanic women in the Southwestern United States. Phytotherapy Research 2006:20: 250-255.
Skrepnek GH, Armstrong EP, Malone DC, Abarca J, Murphy JE, Grizzle AJ, Rehfeld RA, Woosley RL. Workload and the availability of technology in community pharmacy practice. Journal of the American Pharmacist Association 2006; 46(2):154-160.
Abarca J, Malone DC, Skrepnek GH, Rehfeld RA, Murphy JE, Grizzle AJ, Armstrong EP, Woosley RL. Community pharmacy managers’ perception of computerized drug-drug interaction alerts. Journal of the American Pharmacist Association 2006; 46(2):148-153.
Hess LM, Sadoda K, Malone DC, Salache S, Warneke J, Alberts DS. Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer. Cancer Epidemiology and Biomarkers Prevention 2005; 14:2579-2583.
MaloneDC, Tran TT, Poordad FF, Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C. Journal of Managed Care Pharmacy 2005; 11:687-94.
Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Annals of Pharmacotherapy 2005; 39:1785-91.
Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB. Assessment of potential drug–drug interactions with a prescription claims database. American Journal of Health-Systems Pharmacy 2005 62: 1983-1991.
Olson BM, Malone DC, Zachry WM, Coons SJ. Consumer understanding and satisfaction associated with a 3-tier prescription drug benefit. Journal of Managed Care Pharmacy 2005; 11:480-492.
Malone DC, Raebel MA, Porter JA, Lanty FA, Conner DA, Gay EC, Merenich JA, Vogel EA. Cost-effectiveness of sibutramine in the LOSE weight study: evaluating the role of pharmacological weight-loss therapy within a weight management program. Journal of Managed Care Pharmacy 2005; 11:458-468.
Romero AV, Malone DC. Accuracy of adverse-drug-event reports collected using an automated dispensing system. American Journal of Health-System Pharmacy 2005; 62:1375-1380.
Joish VN, Malone DC, Wendel C, Draugalis JR, Mohler MJ. Development and validation of a diabetes severity index (DSI): a risk adjustment tool for predicting healthcare resource use and costs. Pharmacotherapy 2005; 25:676-684.
Skrepnek GH, Armstrong EP, Malone DC, Ramachandran S. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Current Medical Research & Opinion2005; 21(2):261-70.
Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Cohen MD. Longitudinal analysis of the use of etanercept versus infliximab determined from a medical chart audit. Journal of Managed Care Pharmacy 2004; 10:538-542.
Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and non-obese health maintenance organization members. Archives of Internal Medicine 2004: 164:2135-2140.
Armstrong EP, Zachry WM III, Malone DC. Cost-effectiveness analysis of simvastatin and lovastatin/extended-release niacin to achieve LDL and HDL goal using NHANES data. Journal of Managed Care Pharmacy 2004; 10:251-258.
Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen R, Duncan-Edgar BS, Solomon SL, Lipton RL. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. Journal of the American Pharmacist Association 2004: 44:142-151.
Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen R, Lipton RB. Concordance of major drug interaction classifications among drug interaction compendia. Journal of the American Pharmacist Association 2004; 44:136-141.
Joish V, Malone DC, Wendal C, Mohler MJ. Profiling quality of diabetes care in a Veterans Affairs health care system. American Journal of Medical Quality 2004; 19(3);112-120.
Abarca J, Malone DC, Armstrong EP, Zachry III WM. Use of ACE inhibitor therapy among patients with congestive heart failure enrolled in a managed care organization: the effect on hospitalization and costs. Pharmacotherapy 2004; 24: 351-357.
Gardner M, Malone DC, Babington M, Sey M. Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities. Journal of the American Medical Directors Association 2004; 5:101-106.
Malone DC, Luskin AT. Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy. Respiratory Medicine 2003; 97:1269-1276.
Joish V, Malone DC, Miller JM. A cost benefit analysis of vision screening methods for preschoolers and school-aged children. Journal of AAPOS 2003; 7:283-290.
Lackner TE, Heard T, Glunz S, Gann N, Babington M, Malone DC. Gastrointestinal disease control after histamine2-receptor antagonist dose modification for renal impairment in frail chronically-ill elderly patients. Journal of the American Geriatrics Association 2003; 51:650-656.
Lee EK, Malone DC. Comparison of peptic ulcer drug use and expenditure before and after separation of prescribing and dispensing policy in Korea. Clinical Therapeutics 2003; 25: 578-592.
Armstrong EP, Malone DC. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clinical Therapeutics 2003; 25:1-18.
Armstrong EA, Malone DC. Fluticasone propionate is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis. Pharmacotherapy 2002; 22(9):1117-1123.
Malone DC, Armstrong EP. Economic burden of asthma: implications for outcomes and cost-effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research 2001; 1:177-186.
Malone DC, Mubarak-Shaban H. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Annals of Pharmacotherapy 2001; 35:1180-1185.
Okano GJ, Malone DC, Billups SJ, Carter BL, Sintek CD, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Reduced quality of life in veterans at risk for drug related problems. Pharmacotherapy 2001; 21(9):1123-1129.
Gonzales R, Malone DC, Maselli JH, Sande MA. Excess antibiotic use for acute respiratory infections in the United States. Clinical Infectious Diseases 2001:33(6):757-762.
Carter BL, Malone DC, Billups SJ, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. The IMPROVE study: how should the findings be interpreted? American Journal Health-Systems Pharmacy 2001: 58:1330-1337.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High-Risk For Medication-Related Problems? Medical Care 2001:39:109-112.
Carter BC, Billups SJ, Malone DC, Valuck RJ, Barnette, DJ, Sintek CD. Recommended guidelines for pharmacists who provide care for patients in the IMPROVE Study. Federal Practitioner 2001; 18(1):38-46.
Ellis SL, Carter BL, Malone DC, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE Study. Pharmacotherapy 2000; 20(12):1508-1516.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette, DJ, Sintek CD, Okano GJ, Ellis SL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sloboda L, Dombrowski R, Gereats DR, Amato MG. An economic analysis of a randomized controlled multi-center study of clinical pharmacist interventions for high-risk veterans: The IMPROVE Study. Pharmacotherapy 2000; 20(10):1149-1158.
Billups SJ, Malone DC, Carter BL. Economic outcomes of medication non-compliance. Pharmacotherapy 2000; 20(8):941-949.
MacLaughlin EJ, Saseen JJ, Malone DC. Selection and costs of antibiotics for patients with a reported beta-lactam allergy. Archives of Family Medicine 2000; 9:722-726.
Carter BC, Malone DC, Ellis SL, Dombrowski R. Antihypertensive drug utilization in hypertensive veterans with complex medication profiles. Journal of Clinical Hypertension 2000; 2: 172-180.
Ellis SA, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Soloboda L, Sintek CD, Geraets DR, Dombrowski R, Amata M. Ambulatory care clinical pharmacist interventions: The IMPROVE Study. Pharmacotherapy 2000; 20(4):429-435.
Billups SJ, Okano GJ, Malone DC, Carter BL, Valuck RJ, Barnette DJ, Sintek CD. Assessing the structure and process for delivering pharmaceutical care in Veteran Affairs medical centers: The IMPROVE Study. American Journal of Health-System Pharmacy 2000; 57:29-39.
Malone DC, Rascati KL, Martin JD. An analysis of the product-liability costs borne by prescription drug manufacturers. Research in Finance 1999; 17:173-189.
Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication Database. Journal of Clinical Epidemiology 1999;52:551-557.
Malone DC, Okano GJ. Treatment of urge incontinence in Veterans Affairs medical centers. Clinical Therapeutics 1999;21:867-877.
Isaksen SF, Jonassen J, Malone DC, Billups SJ, Carter BL, Sintek CD. Estimating risk factors for patients with potential drug related problems using electronic pharmacy data. The Annals of Pharmacotherapy 1999; 33: 406-412.
Kelly RM, Meyer JD, Matsuura JE, Hart MJ, Malone DC, Manning MC. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Development and Industrial Pharmacy 1999; 25: 15-20.
Lousberg TR, Witt DM, Beall DG, Carter BL, Malone DC. Evaluation of excessive anticoagulation in a group model health maintenance organization. Archives of Internal Medicine 1998; 158: 528-534.
Malone DC, Lackner T, Korenblat BM, Babington M, Yoon P. A clinical and economic comparison of nifedipine CC and nifedipine GITS in long-term care patients. The Consultant Pharmacist 1998; 13(2): 182-192.
Alsuwaidan S, Malone DC, Billups SJ, Carter BL. Description of ambulatory care services provided by veterans affairs medical centers. American Journal of Health-System Pharmacy 1998; 55: 68-73.
Carter BL, Malone DC, Valuck R, Barnette DJ, Sintek C, Billups SJ. The IMPROVE Study: background and study design. American Journal of Health-System Pharmacy 1998; 55: 62-67.
Smith DH, Malone DC, Lawson KL, Okamoto LJ, Battista C, and Saunders WB. A national estimate of the economic costs of asthma. American Journal of Respiratory and Critical Care Medicine 1997; 156: 787-793.
Malone DC, Gwyn BC. Consultant pharmacist services and payment in long-term care facilities. The Consultant Pharmacist 1997; 12: 781-790.
Malone DC, Lawson KA, Smith DH, Arrighi HM, and Battista C. A Cost of illness study of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology 1997; 99: 22-27.
Malone DC, Rascati KL, Gagnon JP. Consumers' Evaluation of a Value-Added Pharmacy Services Program. American Pharmacy 1993; NS33(3): 48-56.